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Abstract 
It is essential to more reliably assess the pro-arrhythmic liability of compounds in 
development. Current guidelines for pre-clinical and clinical testing of drug candidates 
advocate the use of healthy animals/tissues and healthy individuals and focus on the test 
compound’s ability to block the hERG current and prolong cardiac ventricular repolarization. 
Also, pre-clinical safety tests utilize several species commonly used in cardiac 
electrophysiological studies. In this review, important species differences in cardiac 
ventricular repolarizing ion currents are considered, followed by the discussion on electrical 
remodeling associated with chronic cardiovascular diseases that leads to altered ion channel 
and transporter expression and densities in pathological settings. We argue that the choice of 
species strongly influences experimental outcome and extrapolation of results to human 
clinical settings. We suggest that based on cardiac cellular electrophysiology, the rabbit is a 
useful species for pharmacological pro-arrhythmic investigations. In addition to healthy 
animals and tissues, the use of animal models (e.g. those with impaired repolarization reserve) 
is suggested that more closely resemble subsets of patients exhibiting increased vulnerability 
towards the development of ventricular arrhythmias and sudden cardiac death. 
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1. Introduction 
To markedly reduce compound attrition during drug development as well as to prevent 
the relegation or withdrawal of already approved drugs from the market, the efficacy of pro-
arrhythmic liability assessment of drugs needs vast improvement. Many cardiovascular and 
non-cardiovascular compounds have been associated with provoking Torsades de Pointes 
(TdP) arrhythmia (Haverkamp et al, 2000; Redfern et al, 2003), a typical drug-induced 
chaotic ventricular tachycardia that can degenerate into ventricular fibrillation and lead to 
sudden cardiac death (SCD; Fenichel et al, 2004). It is unacceptable to use drugs for non life 
threatening pathologies that can cause SCD, however, in the clinical setting, it is very difficult 
to predict TdP arrhythmia due to its low incidence (Fenichel et al, 2004). Although 
recognized as essential to study, pro-arrhythmic potential is investigated in healthy tissue, 
isolated heart preparations and animals in pre-clinical safety assessment and in healthy 
volunteers as described by current international guidelines (ICH-S7B, 2005; ICH-E14, 2005). 
In addition, most of these tests concentrate on the potential of candidate compounds to block 
hERG current in expression systems, and on the prolongation of action potentials (AP) in 
cardiac tissue, manifested as QT interval prolongation on the surface electrocardiogram. 
However, a growing body of evidence indicates that repolarization prolongation in itself does 
not equal to increased pro-arrhythmic risk (Mattioni et al, 1989; Weissenburger et al, 1991; 
Carlsson et al, 1993; Hondeghem et al, 2001; van Opstal et al, 2001; Belardinelli et al, 2003; 
Thomsen et al, 2004; Anderson, 2006). Crucial issues of phase 3 repolarization disturbances, 
including action potential triangulation (Hondeghem et al, 2001) are not adequately addressed 
by pro-arrhythmic tests. It is clear, that drug-induced arrhythmia episodes occur mostly in 
subsets of patients that are more vulnerable to rhythm disturbances, i.e. mostly in 
cardiovascular and metabolic diseases that involve structural and/or electrical remodeling of 
the heart leading to serious impairments in conduction and/or repolarization. Such common 
examples are: congestive heart failure (Kjekshus, 1990), hypertrophic cardiomyopathy 
(Decker et al, 2009), congenital long-QT syndromes (El-Sherif and Turitto, 1999) and 
diabetes mellitus (McNally et al, 1999; Whitsel et al, 2005). Slowing of the upstroke of the 
action potential and impaired conduction also play key roles in increased arrhythmia 
susceptibility. Changes in connexin expression (Poelzing and Rosenbaum, 2004), structural 
remodeling (chamber enlargement, hypertrophy, fibrosis, etc.) significantly alter conduction 
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and contribute to the arrhythmia substrate and maintenance (Akar et al, 2004). The discussion 
of conduction disturbances is beyond the scope of this paper. 
In this review, we focus on species differences in repolarizing ion currents in animals 
most often used for cardiac electrophysiological and pro-arrhythmic investigations, followed 
by a description of electrical remodeling associated with some common chronic 
cardiovascular diseases, also showing differences among species used in pre-clinical safety 
studies. We strongly argue that the choice of species will significantly influence experimental 
results and their extrapolation to human clinical settings. 
 
2. Species differences in repolarizing potassium currents 
The repolarization of cardiomyocytes is governed by the highly regulated and 
balanced activities of inward and outward currents via different ion channels and electrogenic 
ion pumps (Fig. 1). The value of the rabbit ventricular arrhythmia and pro-arrhythmia models 
largely depend on their predictive capability to human. Human relevance is determined by the 
electrophysiological background of rabbit ventricular myocytes compared to humans and 
other frequently used animal preparations in experimental arrhythmia research or drug testing. 
Mice and rats are commonly used in arrhythmia research and to create transgenic long QT 
(LQT; Table 1) models. They have the advantage of low cost and fairly good predictive 
capability for ischaemia-induced arrhythmias. In small rodents, impulse conduction 
depending on sodium, calcium currents and connexin function, is similar to that in human. 
However, for studies on repolarization, mice and rats have limited value: they have a 
triangular AP (Fig. 2A-E) while humans, dogs and rabbits have a prominent plateau phase 
(Fig. 2F-H) and a rectangular AP (Yang et al, 2014; Nerbonne and Kass, 2005; Saito et al, 
2009; Grandy et al, 2007). The main repolarizing currents in mice and rats are transient 
outward (Ito) and ultrarapid delayed rectifier like (IKur) potassium currents, as opposed to IKr in 
dogs, rabbits and humans. Inhibition of Ito and IKur significantly prolonged AP duration in 
mice and rats (Fig. 2 B and D). The functions of IKr and IKs are still not well explored and 
controversial (Nerbonne and Kass, 2005; Babij et al, 1998; Saito et al, 2009; Grandy et al, 
2007; Yang et al, 2014) in mice. Acute administration of IKr blockers exert no effect on 
ventricular AP in mice and rats (Fig. 2A and C) but prolong repolarization in human, dog and 
rabbit (Fig. 2F-H). However, transgenic LQT1 (genetic loss of IKs function; Table 1) and 
LQT2 (loss of IKr function; Table 1) murine models exhibited arrhythmias and prolonged QT 
intervals (Drici et al, 1998; Babij et al, 1998). A recent report by Yang et al. (Yang et al, 
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2014) may resolve this controversy: prolonged exposure to IKr inhibitors lengthened the AP in 
mice (Fig. 2E) and caused afterdepolarizations. However, the authors found that the IKr 
blocker indirectly (involving the phosphoinositide 3-kinase pathway) augmented the late 
component of INa and prolonged repolarization by increasing an excess of inward current. 
Based on the above, it is assumed that murine transgenic LQT models may have limited 
pharmacological and pathophysiological implications for humans. On the other hand, rabbit 
transgenic LQT models may have more relevance to humans, since rabbits and humans have 
similar cardiac ventricular action potential waveforms and potassium channel expression 
patterns (Figs. 3-5). The function and gating of different types of potassium channels are 
similar in rabbits and humans (Figs. 3-5), with the exception of Ito. Kv1.4 channels are 
responsible for Ito in rabbits that have slower recovery from inactivation than Kv4.3 channels 
expressed in human ventricle (Wang et al, 1999; and own unpublished results). These 
differences may lead to yet unexplored differences in Phase 1 repolarization and arrhythmia 
susceptibility between rabbits and humans. 
In rabbits, IKs and IKr show higher current densities (Fig. 3) with similar gating kinetics 
(Fig. 4) compared to those in human. Also, the repolarization capacity of rabbits (Fig. 5) and 
dogs (Jost et al, 2013) due to higher IK1 current densities is most likely more robust than that 
in human. In contrast to rabbits, guinea pigs lack Ito (Findlay, 2003), and express very strong 
IKs with slow deactivation kinetics compared to rabbit and human ventricles (Lu et al, 2001). 
As the main phase 3 repolarizing current, IKr, is very similar in rabbits and humans, and as the 
other considerations above suggest, rabbits are more useful than rats, mice or guinea pigs for 
electrophysiological, pharmacological antiarrhythmic and pro-arrhythmic investigations. 
 
3. Electrical remodeling in cardiovascular and metabolic diseases: implications for 
arrhythmia susceptibility 
A brief discussion of electrical remodeling associated with cardiovascular diseases is 
necessary to appreciate why it leads to increased sensitivity to arrhythmias and why it is not 
satisfactory to use only healthy animals and tissues for the assessment of TdP liability. During 
the course of a number of cardiovascular diseases (e.g. heart failure, atrial fibrillation, 
myocardial infarction, etc.), in order to maintain intracellular homeostasis and cardiac 
function, characteristic adaptive changes appear in the structure and electrophysiology of the 
heart. These changes are referred to as structural and electrical remodeling, respectively, and 
the longer they persist, the higher the chance for further deterioration of cardiac function and 
7 
 
arrhythmia development. Here we discuss the effects of electrical remodeling on 
repolarization in three chosen clinical entities with repolarization disturbances: congestive 
heart failure, hypertrophic cardiomyopathy and diabetes mellitus. 
In congestive heart failure, cardiac hypertrophy is accompanied by profound electrical 
remodeling and it is consistently found that the Ito (Kaab et al., 1996; Beuckelmann et al., 
1999), the IKs (Li et al, 2004; Li et al, 2002; Tsuji et al, 2000) and IK1 (Li et al, 2004; Rose et 
al, 2005) repolarizing currents are downregulated, while most investigations find that the IKr 
expression does not change (Li et al, 2004; Li et al, 2002; Tsuji et al, 2000). In addition, 
increased slowly inactivating, late sodium current (INa,late) has been shown to contribute to 
APD prolongation and arrhythmias in HF (Valdivia et al, 2005). Therefore, the repolarization 
capacity of failing cardiomyocytes is markedly reduced, leading to the slowing of phase 3 
repolarization and prolongation of the AP and QT intervals (Nuss et al, 1999; Janse, 2004), to 
early afterdepolarization (EAD) formation (Janse, 2004) and to Torsades de Pointes (El-Sherif 
and Turitto, 1999). Accordingly, increased risk of acquired repolarization prolongation was 
found in patients with congestive heart failure (Lehmann et al, 1996). In a rabbit model of HF, 
increased Na+/Ca2+ exchanger (NCX) and decreased IK1 expression have been shown to be 
important contributors to afterdepolarizations and arrhythmias (Pogwizd et al, 2001). The 
hyperpolarization-activated, cyclic nucleotide-gated pacemaker “funny current” (If), normally 
playing a key role in pacemaking in the sinus node (Biel et al, 2002) is upregulated in 
ventricular myocardium in human HF, providing arrhythmogenic triggers (Stillitano et al, 
2008). Based on the above, it is not surprising that approximately 50% of HF patients are lost 
due to SCD resulting from ventricular fibrillation (Kjekshus, 1990), and that compounds with 
mild or moderate ion channel modulating effects can precipitate serious ventricular 
arrhythmias unexpectedly. 
Hypertrophic cardiomyopathy (HCM) is a common hereditary cardiac disease caused 
by different mutations in genes encoding sarcomeric proteins. HCM is characterized by left 
ventricular hypertrophy, myocardial fibrosis and myofiber disarray that may represent an 
arrhythmogenic substrate of the disease (Maron 2002; Gersh et al, 2011). HCM is the most 
common cause of SCD in young individuals (Decker et al, 2009) and in young (<35 years) 
competitive athletes (Maron et al, 2009). Remodeling in HCM is progressive (Olivotto et al, 
2012) and a recently a close correlation was found between the degree of adverse remodeling 
and increased risk for SCD in patients with HCM (Vriesendorp et al, 2014). Although the 
exact elements of ion channel remodeling have not been thoroughly explored in HCM, 
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increased INa,late and beneficial effects of its inhibition have been described in human HCM 
(Coppini et al, 2013.). 
An increased risk for SCD has been identified in patients with both adult and juvenile 
diabetes mellitus (McNally et al, 1999; Whitsel et al, 2005). Prolongation of the frequency 
corrected QT interval (QTc) along with increased QTc dispersion was found in patients with 
type 1 diabetes (Suys et al, 2002; Veglio et al, 2002). The reasons for repolarization 
prolongation and increased arrhythmia sensitivity in diabetes are poorly understood. Most of 
the earlier investigations in this regard were carried out in diabetic rats (Magyar et al, 1992; 
Rusznák et al, 1996; Shimoni et al, 1994; Shimoni et al, 1995; Xu et al, 1996; Tsuchida et al, 
1997). These rat studies observed a significantly descreased amplitude of Ito, that was later 
attributed to lower expression of Kv4.2 and Kv4.3 (Qin et al, 2001). However, as it was 
described in section 2, rat and human ventricular repolarization are very different. 
Consequently, the results of studies on repolarization in diabetic rats can be misleading in the 
understanding of the mechanisms involved in diabetic patients. Subsequent studies have been 
performed in species with artificially induced diabetes that have ventricular repolarization 
more relevant to human. In diabetic dogs, in addition to reduced Ito amplitude, a decreased IKs 
density was found while ICa,L, IK1 and IKr were unaltered (Lengyel et al, 2007). In a study 
performed in diabetic rabbits, Zhang et al (2007) observed reduced IKr, however, other 
repolarizing currents were not investigated in their study. Lengyel et al. (2008) have found 
that IKs density was significantly reduced, however, Ito, IKr, IK1 and ICa,L were not different 
from control in rabbits with diabetes induced by alloxan administration. 
In summary, the pathological alterations in the expression of ion channels can be 
distinctly different in species most commonly used for arrhythmia studies. The remodeling of 
these repolarizing and depolarizing currents lead to decreased repolarizing capacity that in 
turn creates increased susceptibility to arrhythmia development („substrate”) in pathological 
settings. Altered NCX and If expression can provide triggers for arrhythmia initiation. The 
decreased repoarizing capacity is referred to as reduced repolarization reserve, as detailed in 
the following section. 
 
4. Repolarization reserve 
Dr. Roden suggested the concept of repolarization reserve first (Roden, 1998), that 
emphasizes the redundant nature of myocardial repolarizing capacity. The loss or impaired 
function of one or more repolarizing potassium currents, and/or gain of function of inward 
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currents (e.g. LQT3, Table 1) does not always lead to marked repolarization prolongation on 
the ECG, since other currents can compensate. In these cases, however, the heart will be more 
susceptible to additional (even mild) repolarization inhibition and to the development of 
arrhythmias (Roden and Yang, 2005; Varró and Baczkó, 2011). Repolarization reserve 
enables the heart to withstand additional repolarization challenges, and was experimentally 
demonstrated in different species including rabbit (Varró et al, 2000; Biliczki et al, 2002). 
Several repolarizing currents have been implicated in repolarization reserve, however, IKs is 
critical both in experimental animals (Varró et al 2000; Lengyel et al, 2001; Volders et al, 
2003; Abi-Gerges et al, 2006, Lengyel et al, 2007; Johnson et al, 2010) and in humans (Jost et 
al, 2005). A recent study found that IKs densities were lower in human than in rabbit and dogs 
(Jost et al, 2013a), suggesting a weaker repolarization reserve in humans. The kinetics of 
rabbit IKs is more similar to human (Fig. 3) compared to that in guinea-pigs or dogs (Jost et al, 
2013b). The role of IKs in repolarization reserve is well characterized compared to other 
potassium currents. The different IKs density and kinetics data in different species frequently 
used in cardiac electrophysiological studies, however, caution us about the human 
extrapolation of the results. 
Other potassium currents can also be involved in repolarization reserve: Ito may be a 
contributor in dogs (Virág et al, 2011). The IK1 current has been shown to be important in 
dogs (Biliczki et al, 2002), and in patients with LQT7 (Table 1) the loss of function mutations 
in Kir2.1 channels significantly reduce IK1 current and increase pro-arrhythmic risk without 
marked QT prolongation on the ECG (Zhang et al, 2005). However, significant species 
differences exist in the composition of channel subtypes that are eventually responsible for the 
IK1 current (Melnyk et al, 2002; Anumonwo and Lopatin, 2010), leading to different IK1 
current characteristics (Dhamoon et al, 2004). These differences can lead to species dependent 
arrhythmia susceptibilities (Husti et al, 2015) and responses to K+ channel blockers 
(Nerbonne and Kass, 2005). Recently, in line with these differences, dogs and rabbits were 
found to have distinct arrhythmia susceptibilities following the combined pharmacological 
inhibition of IK1, IKs and IKr (Husti et al, 2015). It is likely that due to stronger IK1 and IKs 
found in dogs compared to rabbits and humans, dogs may possess larger repolarization 
reserve than rabbits and humans. In summary, rabbit pro-arrhythmia models with impaired 
repolarization reserve may represent enhanced arrhythmia susceptibility and may be more 
useful than dog models in predicting human electrophysiological changes following 
administration of drugs affecting repolarization. 
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It is important to note that repolarization reserve changes dynamically. Xiao and co-
workers (Xiao et al, 2008) have shown that in cultured adult canine ventricular myocytes a 
one-day incubation with the selective IKr blocker dofetilide, following an expected 
prolongation of the APD at the beginning, led to shortened APD, that is the repolarization 
prolonging effect of dofetilide was blunted. Enhanced IKs was found in dofetilide incubated 
cells compared to control cardiomyocytes, and the results were supported by increased 
KvLQT1 and MinK protein levels, while the mRNA for both of these proteins did not change, 
pointing to the involvement of post-transcriptional regulatory mechanisms. In fact, miR-133a 
and miR-133b expressions were reduced in dofetilide incubated cells. Muscle-specific 
microRNAs repressed IKs-encoding genes without changing the mRNA for KvLQT1 (Luo et 
al, 2007). The results suggest that in case of chronic administration of drugs with cardiac 
potassium channel blocking effects (antibiotics, antipsychotics, antihistamines, NSAIDs, etc.), 
a compensatory IKs upregulation may occur in normal myocardium in an attempt to restore 
normal myocardial repolarization. In case of IKs downregulation (e.g. cardiac hypertrophy) or 
genetic impairment (e.g. LQT1 syndrome), such seemingly harmless compounds may cause 
serious and unexpected repolarization disturbances. The loss of IKs function can be especially 
harmful when sympathetic tone and intracellular cAMP levels are elevated. In this case, the 
IKs mediated repolarization shortening is prevented but APD prolongation by cAMP enhanced 
ICa,L is retained, leading to pro-arrhythmia (Stengl et al, 2006). 
5. In vivo proarrhythmia models with reduced repolarization reserve: role of the rabbit 
Based on the discussion above it is conceivable that in addition to models using 
healthy animals and tissue preparations, models with impaired repolarization reserve are 
needed for more reliable testing of drug-induced arrhythmia liability. As an example 
illustrating the clinical significance of repolarization reserve, we would like to highlight an 
interesting clinical study (Fig. 6), where patients who previously developed TdP („Study 
Group”) due to the administration of QT prolonging compounds responded with a 
significantly more pronounced QTc lengthening to the same test dose of sotalol compared to 
patients without the history of TdP (Kääb et al, 2003). The QTc intervals were similar in both 
groups at baseline, and it is assumed that the markedly different responses to the IKr blocker 
sotalol were due to differences in repolarization reserve in the two groups. 
The first large animal experimental proarrhythmia model with impaired repolarization 
reserve was the dog model with chronic and complete atrioventricular block (Chezalviel et al, 
1995; Vos et al, 1995). This model features bradycardia, eccentric ventricular hypertrophy 
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(Vos et al, 1998), and a marked electrical remodeling with reduced IKs density that contributes 
to increased suceptibility to TdP arrhythmias (Volders et al, 1999; Thomsen et al, 2004). The 
advantages of this model include a stable stage of compensated myocardial hypertrophy 
without deteriorating into heart failure (Schoenmakers et al, 2003), high proarrhythmia 
reproducibility in the same animal (Verduyn et al, 2001). A number of studies used this model 
for the assessment of proarrhythmic side affects of drugs (Chiba et al, 2000; Sugiyama et al, 
2002; Thomsen et al, 2003; Takahara et al, 2006). The disadvantages of this model are related 
to its high cost, a need for special expertise in performing AV ablation, and duration of the 
experiments since several months are needed for the ventricular hypertrophy to develop, 
which is a prerequisite for the increased arrhythmia susceptibility in dogs with AV block (Vos 
et al, 1998). In this model, marked QTc prolongation following amiodarone administration 
did not cause a significant increase in TdP incidence, similarly to observations in humans (van 
Opstal et al, 2001). 
 The first rabbit pro-arrhythmia model investigating the development of TdP in in vivo 
settings was established at the beginning of the nineties by Carlsson and co-workers. One of 
the main aspects of this model is the i.v. administration of the α1-adrenergic agonist 
methoxamine, that is essential for the model’s vulnerability towards ventricular arrhythmias 
(Carlsson et al, 1990; Carlsson et al, 1993). Therefore, it is important to note that test 
compounds with α-adrenergic blocking properties may register as false negative drugs in this 
model. The exact mechanism responsible for methoxamine-induced arrhythmia susceptibility 
is not established, however, α1-adrenergic receptor mediated increase in [Ca2+]i definitely 
plays a role, probably leading to increased triggered activity (Carlsson et al, 1996; Volders et 
al, 2000). The relation of this model to repolarization reserve is not clear, however, the short-
term variability of the QT interval (STVQT), a suggested surrogate biomarker for the 
prediction of ventricular arrhythmias (Berger et al, 1997; Hondeghem et al, 2001; for a 
comprehensive review see Varkevisser et al, 2012), was elevated and showed correlation with 
subsequent arrhythmia development in this model (Jacobson et al, 2011) similarly to other 
rabbit models with impaired repolarization reserve (Lengyel et al, 2007; Major et al, 2016, 
submitted). Also, extensive work has been carried out by Farkas et al. in Langendorff-
perfused rabbit hearts to assess the value of different biomarkers for the prediction of pro-
arrhythmic activities of drugs with special attention to beat-to-beat variability, also influenced 
by intrinsic heart rate changes, termed „absolute beat-to-beat variability (Orosz et al, 2014; 
Sarusi et al, 2014). 
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 Since in the chronic AV-block dog model IKs was shown to be downregulated and 
additional IKr block resulted in high incidence of TdP arrhythmias, it was hypothesized that 
pharmacological inhibition of IKs could similarly prime the heart to arrhythmias by drugs 
exerting additional repolarization inhibition. Indeed, in anesthetized rabbits (and in conscious 
dogs as well) this study showed an increased incidence of TdP when IKs (by HMR1556) and 
IKr (by dofetilide) were inhibited in combination, and the increased incidence of TdP was 
associated with elevated beat-to-beat variability of the QT interval (Lengyel et al, 2007).  In 
contrast to the chronic AV-block canine model, where chronic loss of IKs function is present 
due to IKs downregulation, this rabbit pro-arrhythmia model could refer to a clinical situation 
where compounds with different potassium channel blocking profiles are administered 
concomitantly. The acute i.v. administration of drug combinations in an anesthetized rabbit 
present far fewer technical challenges to investigators compared to the dog model described 
above (Thomsen, 2007). In this model with pharmacologically induced impairment of 
repolarization reserve, the non-steroidal antiinflammatory drug diclofenac increased TdP 
incidence, while it did not alter repolarization in normal rabbit heart tissue and did not cause 
arrhythmias in animals with intact repolarization reserve (Kristóf et al, 2012). In the same 
study diclofenac inhibited IKs and IKr and did not influence Ito and IK1 (Kristóf et al, 2012). 
Combined pharmacological inhibition of not only IKs and IKr, but IK1+IKr and IK1+IKs can also 
lead to impaired repolarization reserve and increased TdP incidence, with rabbits showing 
more sensitivity to IK1+IKr and dogs to IK1+IKs inhibition (Husti et al, 2015). This study 
concluded that the dog and rabbit exhibited different repolarization reserve and arrhythmia 
sensitivity profiles, with possible important relevance to human extrapolation of results 
obtained in these species (Husti et al, 2015). 
 Another experimental approach to reduce repolarization reserve is the genetic 
modification of ion channels involved in cardiac repolarization in transgenic animal models. 
These models could have clinical relevance by representing patients with similar mutations in 
affected ion channels, however, the choice of species – mouse versus rabbit - is very 
important for obtaining clinically meaningful results. The first two transgenic LQT rabbit 
models were created by Brunner et al (2008), overexpressing the dominant-negative mutants 
of the pore-forming human KvLQT1 (LQT1) or HERG channels (LQT2), respectively. These 
landmark transgenic rabbit models are expertly discussed in another review of this issue by 
Lang et al (2016, this issue, in press). These rabbit LQT models exhibited a strong phenotype, 
including prolongation of the action potential and QT intervals, and spontaneous SCD in 
LQT2 rabbits (Brunner et al, 2008). In order to achieve a somewhat milder impairment of 
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repolarization reserve, a model would be needed where the incidence of spontanous 
arrhythmias was lower with retained increased susceptibility to arrhythmias. For this purpose, 
targeting the β-regulatory subunit of the IKs channel, minK (encoded by KCNE1) was 
identified. 
Although transgenic mouse models were previously created affecting the IKs channel, 
including KCNE1 knockout (Drici et al, 1998), knock-in (Nishio et al, 2009; Rizi et al, 2008) 
and dominant negative loss-of-function mutation (Demolombe et al, 2001) models, mice have 
approximately 10 times faster heart rates and a number of important differences in their 
cardiac repolarization compared to humans (Nerbonne and Kass, 2005). Therefore, it is not 
surprising that transgenic mouse models can only mimic some aspects of the human LQT 
phenotype (Salama and London, 2007). To create a transgenic rabbit model with milder 
impairment of repolarization reserve, the heart specific overexpression of the human mutant 
KCNE1, carrying a G52R missense mutation was performed in rabbits (Major et al, 2016, in 
press). This mutation was first identified in a Chinese LQT family (Ma et al, 2003). In this 
family, seven individuals were mutation carriers, five of them were clinically affected, on the 
other hand, the ECG was normal in two family members (Ma et al, 2003). A dominant-
negative effect of the mutant G52R-KCNE1 was described, reducing IKs current amplitude by 
50% (Ma et al, 2003). It was shown subsequently that the G52R mutation did not affect 
channel-subunit assembly or channel trafficking, but resulted in KCNE1 to be unable to 
modulate the gating properties of KCNQ1 (Harmer et al, 2010). These G52R-KCNE1 
overexpressing animals were subjected to a marked repolarization challenge by the i.v. 
administration of the IKr blocker dofetilide (Major et al, 2016, in press). At baseline, before 
dofetilide administration, the heart rate corrected QT-index of the LQT5 animals was mildly 
but significantly longer, and had a significantly higher STVQT. A significantly larger number 
of animals developed TdP following dofetilide administration, paralleled by a further increase 
in STVQT. Patch-clamp studies in isolated ventricular myocytes surprisingly did not show 
differences in IKs current amplitude, however, demostrated accelerated IKs and IKr deactivation 
kinetics in LQT5 transgenic rabbits compared to their wild-type littermates (Major et al, 2016, 
in press). It was concluded that LQT5 transgenic rabbits exhibited increased arrhythmia 
susceptibility and may represent a promising model for testing the pro-arrhythmic potential of 
candidate compounds. Further studies are needed to validate this model using drugs with 
proven pro-arrhythmic liability. 
It has to be mentioned that the anesthetic protocol used in the rabbit in vivo pro-
arrhytmia studies can have profound effects on the development of arrhythmias (Odening et 
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al, 2008; Vincze et al, 2008). In this regard, xylazine/ketamine-anaesthesia can be 
recommended, since it does not seem to affect repolarizing currents (Odening et al, 2008). 
As described in section 3, hypertrophic cardiomyopathy is associated with increased 
incidence of SCD, and the assessment of SCD risk is incomplete since established SCD risk 
factors demonstrated only a low positive predictive value (McKeown and Muir, 2013). 
Therefore, for estimation of HCM associated arrhythmia risk, an animal model of HCM in a 
species that has similar repolarization and repolarization reserve profile to humans would be 
very useful.  Interestingly, transgenic rabbit models of HCM were described as early as 1999 
(Marian et al, 1999). However, few studies investigating arrhythmia mechanisms in 
transgenic HCM rabbits can be found in the literature, mainly concentrating on pathological 
aspects of conduction in this model (Ripplinger et al, 2007; Lombardi et al, 2009). A recent 
clinical study from our group found increased short-term variability of the QT interval that 
highly correlated with indices of left ventricular hypertrophy in patients with HCM (Orosz et 
al, 2015). Therefore, it is recommended that further studies are performed in transgenic 
rabbits with HCM regarding repolarization abnormalities and sensitivity of the animals to 
drug-induced arrhythmias. 
 
6. Conclusions 
Current guidelines for pre-clinical and clinical testing of drug-induced arrhythmia liability 
mostly utilize healthy animals or individuals and concentrate on whether the test compound 
prolongs ventricular repolarization, or blocks the hERG current in cellular expression 
systems. Significantly less attention is paid to key issues of phase 3 repolarization 
disturbances such as AP triangulation, reverse use dependence of AP prolongation and spatial 
dispersion and temporal instability of repolarization. Also, in addition to K+ current 
disturbances, alterations (increases and reductions) in inward currents can also destabilize 
repolarization and provoke TdP (Hondeghem et al, 2010). For pre-clinical testing, several 
animal species are used. In this review, we have discussed important species differences in 
cardiac ventricular repolarizing currents, as well as the substantial structural and electrical 
remodeling associated with chronic cardiovascular diseases, leading to very different cardiac 
ion channel and/or transporter expression in pathological settings and to reduction of the 
repolarizing capacity of the heart, i.e. impairment of repolarization reserve. Remarkably, these 
pathological expression changes can also show differences among species used in pre-clinical 
safety studies. 
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 Therefore, the choice of species markedly influences experimental outcome and 
extrapolation of results to human clinical settings. We argue that based on cellular ventricular 
electrophysiology, the rabbit should be a useful species for electrophysiological, 
pharmacological antiarrhythmic and pro-arrhythmic investigations. In particular, the 
repolarization reserve of the rabbit resembles human repolarization reserve similarly as that 
found in dogs. 
However, for practical reasons, advantages of rabbit models should be mentioned 
compared to canine models, these include reduced cost (breeding, animal keeping), the 
already existing and proven technology for the creation of transgenic animals and favorable 
ethical considerations (the rabbit is not a pet animal), in spite of the fact that the size of the 
heart and heart rates of the dog are similar to those in humans. 
In conclusion, in cardiac safety testing, although the investigations on healthy animals 
and individuals are still important, the addition of models recapitulating human disease are 
definitely needed. These additions are justified in order to test compounds in models that 
more closely resemble patient subpopulations with increased vulnerability to ventricular 
arrhythmias and sudden cardiac death, such as congestive heart failure, hypertrophic 
cardiomyopathy, congenital LQT syndromes and diabetes mellitus. 
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Figure 1. Illustration of the main transmembrane ionic currents and electrogenic pumps 
shaping the ventricular cardiac action potential. Specific blockers are also included. The 
transmembrane currents shown are not proportional to the actual current densities. Channel 
proteins that mediate these currents are also indicated. Reproduced from Varró and Baczkó, 
2011, with permission. 
 
Figure 2. Representative action potential recordings from different species frequently used in 
cardiac electrophysiological research. (A) The lack of effect of acute administration of the IKr 
blocker dofetilide, and the prolonging effect of 4-aminopyridine (4-AP) (B) on action 
potentials in mice. (C) Lack of effect of the IKr blocker sotalol on the AP in a rat papillary 
muscle preparation. (D) The significant AP prolonging effect of the combined Ito and IKur 
inhibitor AVE0118 in rat. (E) Extended (5 h) application of dofetilide prolonged the AP in 
mice. Sotalol exerts significant AP lengthening effect in (F) humans, (G) dogs, and (H) 
rabbits. Panels A, B and E reproduced from Yang et al, 2014; panel D from Nagy et al, 2009; 
panel F from Jost et al, 2013; panel G from Varró et al, 2000, with permission. Panels C and 
H show unpublished results from our laboratory. 
 
Figure 3. (A) Original recordings of E-4031 sensitive (IKr, left) and L-735.821 (IKs, right) 
rapid and slow delayed rectifier potassium currents in undiseased human (top), and rabbit 
(bottom) ventricular myocytes. Nisoldipine (1 µM) was used to block L-type inward calcium 
current (ICaL) and L-735,821 (100 nM) or E-4031 (1 µM) to block IKr or IKs currents, 
respectively. (B) The peak IKr (left) and IKs (right) tail current-voltage (I-V) relationship in 
undiseased human (triangles) and rabbit (diamonds) ventricular myocytes. IKr and IKs currents 
were examined in isolated human or rabbit ventricular myocytes using test pulses of 1000 ms 
(IKr) or 5000 ms (IKs) in duration to between -20 mV and +50 mV from the holding potential 
of -40 mV. The pulse frequency was 0.05 Hz (IKr) or 0.1 Hz (IKs). Unpublished data from our 
laboratory. 
 
Figure 4. Activation and deactivation kinetics of IKr (A) and IKs (B), in undiseased human 
(left) and rabbit (right) ventricular myocytes. Activation kinetics of IKr and IKs were measured 
as tail currents at -40 mV, after test pulses to +30 mV with duration gradually increasing 
between 10 and 5000 ms. Deactivation kinetics of IKr and IKs outward tail currents were 
measured at -40 mV, after a 1000 ms (for IKs) or 5000 ms (for IKs), respectively, long test 
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pulse to +30 mV. Average IKr and IKs activation and deactivation time constants () 
values±SEM are given in insets. Adapted from Iost et al, 1998; Virag et al, 2001 and Lengyel 
et al, 2001, with permission. 
 
Figure 5. (A) Original recordings of inward rectifier potassium (IK1) currents in undiseased 
human (left), and rabbit (right) ventricular myocytes. IK1 current was studied by measuring the 
steady-state current level at the end of the 400 ms long voltage pulse in the voltage range of -
120 to 0 mV with a pulse frequency of 0.33 Hz. The holding potential was -90 mV. 
Nisoldipine (1 µM) was used to block L-type inward calcium current. (B) Current-voltage 
relationships of IK1 current in human (circle) and rabbit (triangle) ventricular myocytes 
measured after depolarizing voltage steps beetween -80 mV to 0 mV (outward range of IK1 
current). Values represent mean±SEM. Insets show applied voltage protocols on both panels. 
Adapted from Jost et al., 2013, with permission and unpublished data from our laboratory. 
 
Figure 6. Clinical significance of repolarization reserve. Changes in individual QTc intervals 
in control patients (A) and in patients with suspected acquired long QT syndrome (B, Study 
Group) following the i.v. administration of sotalol. The dotted line represents the cut-off value 
of 480 ms that differentiated between the study group and the control group. From Kääb et al, 
2003, with permission. 
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Type Affected gene Affected protein – ionic current Mutation result 
LQT1 KCNQ1 KVLQT1 - IKs loss of function 
LQT2 KCNH2 KV11.1 - IKr loss of function 
LQT3 SCN5A NaV1.5 - INa gain of function 
LQT4 ANKB Ankyrin-B – INCX, INaK loss of function 
LQT5 KCNE1 (minK) MinK - IKs loss of function 
LQT6 KCNE2 (MiRP1) MiRP1 - IKr loss of function 
LQT7 KCNJ2 Kir2.1 - IK1 loss of function 
LQT8 CACNA1c CaV1.2α1 - ICa,L gain of function 
LQT9 CAV3 Caveolin- INa  
LQT10 SCN4B Navβ4- INa gain of function 
LQT11 AKAP9 Yotiao – IKs loss of function 
LQT12 SNTA1 α-syntrophin - INa gain of function 
LQT13 KCNJ5 Kir3.4 - IK,ACh loss of function 
 
Table 1. List of congenital long QT syndromes, affected genes, proteins and ionic currents. 
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Figure 1. Illustration of the main transmembrane ionic currents and electrogenic pumps shaping the 
ventricular cardiac action potential. Specific blockers are also included. The transmembrane currents 
shown are not proportional to the actual current densities. Channel proteins that mediate these currents 
are also indicated. Modified from Varró and Baczkó, 2011, with permission. 
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Figure 2. Representative action potential recordings from different species frequently used in cardiac 
electrophysiological research. (A) The lack of effect of acute administration of the IKr blocker 
dofetilide, and the prolonging effect of 4-aminopyridine (4-AP) (B) on action potentials in mice. (C) 
Lack of effect of the IKr blocker sotalol on the AP in a rat papillary muscle preparation. (D) The 
significant AP prolonging effect of the combined Ito and IKur inhibitor AVE0118 in rat. (E) Extended 
(5 h) application of dofetilide prolonged the AP in mice. Sotalol exerts significant AP lengthening 
effect in (F) humans, (G) dogs, and (H) rabbits. Panels A, B and E reproduced from Yang et al, 2014; 
panel D from Nagy et al, 2009; panel F from Jost et al, 2013; panel G from Varró et al, 2000, with 
permission. Panels C and H show unpublished results from our laboratory. 
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Figure 3. (A) Original recordings of E-4031 sensitive (IKr, left) and L-735.821 (IKs, right) rapid and 
slow delayed rectifier potassium currents in undiseased human (top), and rabbit (bottom) ventricular 
myocytes. Nisoldipine (1 µM) was used to block L-type inward calcium current (ICaL) and L-735,821 
(100 nM) or E-4031 (1 µM) to block IKr or IKs currents, respectively. (B) The peak IKr (left) and IKs 
(right) tail current-voltage (I-V) relationship in undiseased human (triangles) and rabbit (diamonds) 
ventricular myocytes. IKr and IKs currents were examined in isolated human or rabbit ventricular 
myocytes using test pulses of 1000 ms (IKr) or 5000 ms (IKs) in duration to between -20 mV and +50 
mV from the holding potential of -40 mV. The pulse frequency was 0.05 Hz (IKr) or 0.1 Hz (IKs). 
Unpublished data from our laboratory. 
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Figure 4. Activation and deactivation kinetics of IKr (A) and IKs (B), in undiseased human (left) and 
rabbit (right) ventricular myocytes. Activation kinetics of IKr and IKs were measured as tail currents at -
40 mV, after test pulses to +30 mV with duration gradually increasing between 10 and 5000 ms. 
Deactivation kinetics of IKr and IKs outward tail currents were measured at -40 mV, after a 1000 ms 
(for IKs) or 5000 ms (for IKs), respectively, long test pulse to +30 mV. Average IKr and IKs activation 
and deactivation time constants () values±SEM are given in insets. Adapted from Iost et al, 1998; 
Virag et al, 2001 and Lengyel et al, 2001, with permission. 
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Figure 5. (A) Original recordings of inward rectifier potassium (IK1) currents in undiseased human 
(left), and rabbit (right) ventricular myocytes. IK1 current was studied by measuring the steady-state 
current level at the end of the 400 ms long voltage pulse in the voltage range of -120 to 0 mV with a 
pulse frequency of 0.33 Hz. The holding potential was -90 mV. Nisoldipine (1 µM) was used to block 
L-type inward calcium current. (B) Current-voltage relationships of IK1 current in human (circle) and 
rabbit (triangle) ventricular myocytes measured after depolarizing voltage steps beetween -80 mV to 0 
mV (outward range of IK1 current). Values represent mean±SEM. Insets show applied voltage 
protocols on both panels. Adapted from Jost et al, 2013, with permission and unpublished data from 
our laboratory. 
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Figure 6. Clinical significance of repolarization reserve. Changes in individual QTc intervals in 
control patients (A) and in patients with suspected acquired long QT syndrome (B, Study Group) 
following the i.v. administration of sotalol. The dotted line represents the cut-off value of 480 ms that 
differentiated between the study group and the control group. From Kääb et al, 2003, with permission. 
 
